Assessment of autonomic symptoms in a medically complex, urban patient population.

Assessment of autonomic symptoms in a medically complex, urban patient population.
复制标题

DOI:
10.1007/s10286-016-0384-4
复制
发表时间:
2017-03
期刊:
Clinical autonomic research : official journal of the Clinical Autonomic Research Society
影响因子:
--
通讯作者:
Simpson DM
Simpson DM
中科院分区:
其他
文献类型:
--
作者:
Robinson-Papp J;Sharma SK;George MC;Simpson DM

文献摘要

参考文献

被引文献

相似文献

Urban, minority communities are disproportionately affected by the chronic diseases associated with autonomic neuropathy; however validated measures of autonomic symptoms have not been studied in these complex populations. We sought to validate the Autonomic Symptom Profile (ASP) in a low income, medically complex, urban patient population. Ninety-seven adults were recruited from the outpatient neurology clinic of an academic medical center serving the East Harlem neighborhood of New York City. Participants completed the ASP, and underwent a comprehensive neurologic examination, and a standardized battery of autonomic function tests (quantitative sweat testing, heart rate response to deep breathing (HRDB), Valsalva maneuver, and tilt table). Burden of chronic disease was summarized using the Charlson co-morbidity index (CCI), and detailed medication history was obtained. The ASP displayed good internal consistency (Cronbach’s α =.88), even among lower literacy participants. In univariate analyses, the ASP was correlated with HRDB (r=−.301, p=.002), a marker of cardiac autonomic neuropathy, with the CCI (r=.37, p<.001), and with use of medications with autonomic effects (t(95)=−2.13, p=.036). However, in multivariate analysis, only the CCI remained significant. In this urban, predominantly minority patient population, the symptoms captured by the ASP were more closely associated with burden of medical disease than with autonomic dysfunction. Due to this lack of specificity, it is essential that results from autonomic questionnaires be interpreted in the context of the neurologic history and exam, burden of co-morbid illness and medications, and most importantly autonomic function tests.
DOI: 10.1016/s0025-6196(12)60631-4
发表时间: 1993-08-01
影响因子: 8.9
作者:
LOW, PA
通讯作者: LOW, PA
DOI: 10.1007/s13365-013-0160-3
发表时间: 2013-04
影响因子: 3.2
作者:
Robinson-Papp, Jessica;Sharma, Sandeep;Simpson, David M.;Morgello, Susan
通讯作者: Morgello, Susan
DOI: 10.1097/rhu.0b013e3181a1083d
发表时间: 2009-06-01
影响因子: 3.4
作者:
Solano, Carla;Martinez, Aline;Martinez-Lavin, Manuel
通讯作者: Martinez-Lavin, Manuel
DOI: 10.1016/0021-9681(87)90171-8
发表时间: 1987-01-01
期刊: JOURNAL OF CHRONIC DISEASES
影响因子: --
作者:
CHARLSON, ME;POMPEI, P;MACKENZIE, CR
通讯作者: MACKENZIE, CR
DOI: 10.1001/archneurol.2009.295
发表时间: 2010-01-01
影响因子: --
作者:
Shulman, Lisa M.;Gruber-Baldini, Ann L.;Weiner, William J.
通讯作者: Weiner, William J.